2nd ITP Update Day

Virtual Event live from the Cavendish Conference Centre

Organiser: Dr Nichola Cooper, Imperial College London
Chairs for the Day: Dr Nichola Cooper and Professor Adrian Newland

room 22 Duchess Mews, London W1G 9DT

  • Thursday 8th October 2020

  • Chairs for the Day

    Dr Nichola Cooper & Professor Adrian Newland, London

  • 10:00

    Introduction

    Dr Nichola Cooper, London

  • 10:10

    The ITP Forum

    Dr Quentin Hill, Leeds

  • Developing Networks ERCI

  • 10:20

    Updates

    Professor Francesco Rodeghiero, Vincenza

  • 10:40

    Questions

    Professor Francesco Rodeghiero, Vincenza

    Dr Nichola Cooper & Professor Adrian Newland, London

  • 10:50

    Coffee break

  • Real Life Data

  • 11:05

    Real world data for TPO receptor agonists - summary

    Dr Vickie McDonald, London

  • 11:20

    Real world data from the French Registry

    Dr Guillaume Moulis, Tolouse

  • 11:25

    Thrombosis and ITP

    Dr Guillaume Moulis, Toulouse

  • 11:40

    Questions

    Dr Guillaume Moulis, Toulouse

    Dr Waleed Ghanima, Oslo

    Dr Nichola Cooper & Professor Adrian Newland, London

  • 12:00

    Cases for discussion

    Dr Alice Hart, London

    Dr Nichola Cooper & Professor Adrian Newland, London

  • 12:15

    Lunch

  • Guidelines and Sequencing Therapy

  • 13:00

    Guidelines presented

    Dr Drew Provan, London

  • 13:20

    ASH Guidelines

    Professor Douglas Cines, Pennsylvania

  • 13:40

    Panel discussion Q & A

    Dr Nichola Cooper, & Professor Adrian Newland, London

    Professor Douglas Cines, Pennsylvania

    Professor Marc Michel, Paris

    Professor Francesco Rodeghiero, Vincenza

    Dr Drew Provan, London

  • COVID-19 Update

  • 14:00

    Introduction

    Dr Nichola Cooper, London

  • 14:05

    Discussion with France

    Professor Marc Michel, Paris

  • 14:20

    Panel discussion Q & A

    Dr Nichola Cooper, & Professor Adrian Newland, London

    Professor Douglas Cines, Pennsylvania

    Professor Marc Michel, Paris

    Professor James Bussel, New York

  • 14:45

    Coffee break

  • New Treatments

  • 15:00

    Fostamatinib

    Dr Nichola Cooper, London

  • 15:20

    FcRn antagonists: Rozanolixizumab and Efgartigimod

    Professor James Bussel, New York

  • 15:45

    BTK inhibitors and complement inhibition Rilzabrutinib

    Professor David Kuter, Massachusetts

  • 16:05

    Questions

    Professor David Kuter, Massachusetts

    Professor James Bussel, New York

    Dr Camelia Vladuscu, London

    Dr Nichola Cooper & Professor Adrian Newland, London

  • 16:30

    Summary and close

    Dr Nichola Cooper & Professor Adrian Newland, London